Zura Bio Ltd Files Updated Corporate Presentation (Aug 17, 2026)

What Happened

• On August 17, 2026, Zura Bio Limited filed a Form 8-K (Item 7.01 — Regulation FD Disclosure) to furnish an updated corporate presentation the company may use in upcoming conferences and investor meetings.
• The presentation is filed as Exhibit 99.1 to the 8-K and is also available in the “News & Events” section of Zura Bio’s investor website (investors.zurabio.com).

Key Details

• Filing date: August 17, 2026.
• Exhibit filed: 99.1 — Corporate Presentation (dated August 17, 2026).
• Purpose: For use in upcoming presentations at conferences and investor meetings; provided under Regulation FD to ensure public disclosure.
• Presentation is accessible on the company’s investor website and via the SEC filing.

Why It Matters

• This 8-K does not report earnings, executive changes, mergers, or new financial results; it simply makes an updated investor presentation public.
• Investors should review the filed presentation (Exhibit 99.1) for any updates on the company’s strategy, pipeline, timelines, or other disclosures that management may present publicly — because providing it under Regulation FD helps prevent selective disclosure.
• For specific financial or material updates, wait for separate filings or formal announcements (e.g., earnings releases, 10-Q/10-K, or other Item-based 8-Ks).